Join us for the upcoming RAPS Nordic Local Networking Group (LNG) physical event hosted at Novo Nordisk HQ in Bagsværd, Denmark, on 27 November 2025. This free, half-day gathering will explore critical regulatory challenges for innovative health technologies - specifically Drug-Device Combination Products and AI/ML-Enabled Medical Devices.
The event will explore the challenges of navigating the regulatory landscape for emerging technologies - such as combination products and AI/ML-enabled medical devices - particularly in areas where standardization and guidance remain slow to develop or fragmented in interpretation.
The event will consist of two targeted presentations, followed by a panel discussion featuring representatives from Notified Bodies and Competent Authorities only.
Topics include:
- Presentation 1: This presentation explores how adopting a platform approach can enhance regulatory compliance in the development of integrated Drug-Device Combinations (iDDCs) and medical devices.
- Presentation 2: This session dives into the challenges of benefit-risk determination for AI/ML-enabled medical devices, providing an overview of emerging guidance and standardisation efforts in clinical and performance evaluation.
- Panel Discussion and Q&A: This session will address the ongoing regulatory uncertainty surrounding clinical evidence requirements for AI/ML-enabled medical devices and the broader compliance challenges for combination products.
Attendees will have the opportunity to engage with Competent Authorities and Notified Bodies, network with peers, and enjoy a networking session with complimentary snacks and beverages.
Registration Fees & Deadlines
Free
Agenda
All times are in CET.
13.00 – 13.30 Arrival, Ice Breaker & Mingle
13.30 – 14.00 Presentation #1
- Presenter: Ola Oyinloye (Novo Nordisk)
- Theme: Streamlining Regulatory Compliance: A Platform Approach to Advancements in integrated Drug-Device Combinations (iDDCs) and Medical Devices
14.00 – 14.30 Presentation #2
- Presenters: Edward Ball (RQM+) & Jonas A. Bundgaard (NorMed Consulting)
- Theme: Benefit-Risk determination for AI/ML-enabled Medical Devices: Current challenges, upcoming guidance and ongoing standardisation efforts
14.30 – 15.00 Coffee Break
15.00 – 16.15 Panel Discussion and Q&A
16.15 – 17.00 Networking and end
Speakers
Jonas A. Bundgaard
Owner & Principal Consultant (NorMed Consulting)
Richard Holborow
Global Head Clinical Compliance (BSI)
Simon Lidgate
Technical Team Manager, Clinical, AIMD and SaMD (BSI)
Alexey Shriyaev
Global Head of Clinical and Regulatory Affairs (DNV)
Ilkka Juuso
Lead Auditor, SGS Fimko
Ola Oyinloye
Director CMC Regulatory Affairs and Devices, Platform and Portfolio, Novo Nordisk
Edward Ball
Manager, Intelligence and Strategic Execution, RQM+
Location
Novo Nordisk
Novo Alle 1
Bagsværd, Copenhagen, Denmark
Proof of Attendance
A certificate of attendance can be downloaded from the RAPS Learning Portal following the event.
Questions
Contact the RAPS Support Center:
Call +1 301 770 2920, ext. 200 (8:30 am–5:30 pm EST, Monday–Friday) or email
support@raps.org.